Dr. Platt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Sumneytown Pike
Gwynedd, PA 19454Phone+1 267-305-1922- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2012 - 2014
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008 - 2011- Rutgers New Jersey Medical SchoolClass of 2008
Certifications & Licensure
NJ State Medical License 2010 - 2025
NY State Medical License 2012 - 2015
Publications & Presentations
PubMed
- 18 citationsSafety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator...Heather Platt, Tosin Omole, Jose Cardona, Neil J Fraser, Richard A Mularski, Charles Andrews, Nizar Daboul, Nancy Gallagher, Aditi Sapre, Jianing Li, Adam Polis, Doree...> ;The Lancet. Infectious Diseases. 2023 Feb 1
- 12 citationsElbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study.Ira M. Jacobson, Fred Poordad, Roberto J. Firpi-Morell, Gregory T. Everson, Elizabeth C. Verna, S. Bhanja, Peggy Hwang, Luzelena Caro, Michael N. Robertson, Edgar D. C...> ;Clinical and Translational Gastroenterology. 2019 Mar 28
- 37 citationsEfficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trialJan Sperl, Gabor Horvath, Waldemar Halota, Juan Ignacio Arenas Ruiz-Tapiador, Anca Streinu-Cercel, Ligita Jancoriene, Klára Werling, Hege Kileng, Seyfettin Köklü, Jan ...> ;Journal of Hepatology. 2016 Dec 1
- Join now to see all
Press Mentions
Emerging Infectious Diseases Prompt a Layered ResponseAugust 16th, 2023- CMV Vaccine Trials: Moderna’s CMV mRNA Vaccine Enters Phase IIIFebruary 20th, 2024
- Pancreatic Cancer Clinical Trials: Insights from PanCAn’s Senior DirectorDecember 16th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
